Jeffrey Johnson

Prof. Jeffrey Johnson

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Cell
Verified
Journal Article
Closed access
MBMehdi Bouhaddou
Mehdi Bouhaddou
DMDanish Memon
Danish Memon
BMBjoern Meyer
Bjoern Meyer
KWKris White
Kris White
VRVeronica V. Rezelj
Veronica V. Rezelj
NKNevan J. Krogan
Nevan J. Krogan

1 December 2018 in Cell
Verified
Journal Article
Closed access
PSPriya S. Shah
Priya S. Shah
NLNichole Link
Nichole Link
GJGwendolyn M. Jang
Gwendolyn M. Jang
PSPhillip P. Sharp
Phillip P. Sharp
TZTongtong Zhu
Tongtong Zhu
NKNevan J. Krogan
Nevan J. Krogan

8 July 2020 in Nature
Verified
Journal Article
Closed access
PDF file
MGMaria Isabel Giraldo Giraldo
Maria Isabel Giraldo Giraldo
HXHongjie Xia
Hongjie Xia
LALEOPOLDO AGUILERA-AGUIRRE
LEOPOLDO AGUILERA-AGUIRRE
AHAdam Hage
Adam Hage
STSarah van Tol
Sarah van Tol
RRRicardo Rajsbaum
Ricardo Rajsbaum

1 August 2018 in Molecular Cell
Verified
Journal Article
Closed access
BPBennett H. Penn
Bennett H. Penn
ZNZoe Netter
Zoe Netter
JJJeffrey Johnson
Jeffrey Johnson
JDJohn Von Dollen
John Von Dollen
GJGwendolyn M. Jang
Gwendolyn M. Jang
NKNevan J. Krogan
Nevan J. Krogan

14 March 2018 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
SMSang-Won Min
Sang-Won Min
PSPeter Dongmin Sohn
Peter Dongmin Sohn
YLYaqiao Li
Yaqiao Li
NDNino Devidze
Nino Devidze
JJJeffrey Johnson
Jeffrey Johnson
LGLi Gan
Li Gan
Hyperacetylation of tau has been implicated in neurodegeneration and cognitive decline in tauopathy brains. The nicotinamide adenosine dinucleotide-dependent class-III protein deacetylase SIRT1 is one of the major enzymes involved in removal of acetyl groups from tauin vitro. However, whether SIRT1 regulates acetylation of pathogenic tau and ameliorates tau-mediated pathogenesis remains unclear. Here, we report deacetylating activity of SIRT1 for acetylated Lys174 (K174) of tau in tauP301S transgenic mice with a brain-specific SIRT1 deletion. We show that SIRT1 deficiency leads to exacerbation of premature mortality, synapse loss, and behavioral disinhibition in tauP301S transgenic mice of both sexes. By contrast, SIRT1 overexpression by stereotaxic delivery of adeno-associated virus that encodes SIRT1 into the hippocampus reduces acetylated K174 tau. Furthermore, SIRT1 overexpression significantly attenuates the spread of tau pathology into anatomically connected brain regions of tauP301S transgenic mice of both sexes. These findings suggest the functional importance of SIRT1 in regulating pathogenic tau acetylation and in suppressing the spread of tau pathologyin vivo.SIGNIFICANCE STATEMENTIn neurodegenerative disorders with inclusions of microtubule-associated protein tau, aberrant lysine acetylation of tau plays critical roles in promoting tau accumulation and toxicity. Identifying strategies to deacetylate tau could interfere with disease progression; however, little is known about how pathogenic tau is deacetylatedin vivo. Here we show that the protein deacetylase SIRT1 reduces tau acetylation in a mouse model of neurodegeneration. SIRT1 deficiency in the brain aggravates synapse loss and behavioral disinhibition, and SIRT1 overexpression ameliorates propagation of tau pathology.

8 April 2019 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
PDF file
AOAdam L. Orr
Adam L. Orr
CKChaeyoung Kim
Chaeyoung Kim
DJDavid Jimenez-Morales
David Jimenez-Morales
BNBilly W. Newton
Billy W. Newton
JJJeffrey Johnson
Jeffrey Johnson
RMRobert W. Mahley
Robert W. Mahley
Apolipoprotein (apo) E4, the major genetic risk factor for Alzheimer’s disease (AD), alters mitochondrial function and metabolism early in AD pathogenesis. When injured or stressed, neurons increase apoE synthesis. Because of its structural differenc